ARTICLE | Clinical News
BiovaxID regulatory update
July 23, 2012 7:00 AM UTC
Accentia's Biovest International Inc. (OTCQB:BTVI, Tampa Fla.) subsidiary said EMA formally notified the subsidiary that an MAA for BiovaxID to treat follicular non-Hodgkin's lymphoma (NHL) is eligib...